- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vessel analysis programs underrate carotid disease
Semiautomated vessel analysis software tends to underestimate the degree of carotid stenosis, particularly at levels that require corrective action, according to a study presented at the 2006 RSNA meeting.
Semiautomated vessel analysis software tends to underestimate the degree of carotid stenosis, particularly at levels that require corrective action, according to a study presented at the 2006 RSNA meeting.
Dr. William Boonn and colleagues analyzed data from 12 patients undergoing carotid angiography using multislice CT and six commercially available vessel analysis systems. They found underestimation of stenosis greater than 70% that ranged from 12% to 50%. The estimates worsened as degree of stenosis increased. However, they also found these vessel analysis systems provide improved visualization and other benefits. Study results suggest that vendors must improve the consistency and accuracy of automated stenosis measurements, Boonn said.
Boonn, an imaging informatics fellow at VA Maryland Health Care System when the study was conducted, currently works at the University of Pennsylvania.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
